Cholesteryl	cholesteryl	O	O
hemisuccinate	hemisuccinate	O	O
treatment	treatment	O	O
protects	protects	O	O
rodents	rodents	O	O
from	from	O	O
the	the	O	O
toxic	toxic	O	O
effects	effects	O	O
of	of	O	O
acetaminophen	acetaminophen	S_chemical	O
,	,	O	O
adriamycin	adriamycin	S_chemical	O
,	,	O	O
carbon	carbon	B_chemical	O
tetrachloride	tetrachloride	I_chemical	O
,	,	O	O
chloroform	chloroform	O	O
and	and	O	O
galactosamine	galactosamine	O	O
.	.	O	O

In	in	O	O
addition	addition	O	O
to	to	O	O
its	its	O	O
use	use	O	O
as	as	O	O
a	a	O	O
stabilizer/rigidifier	stabilizer/rigidifier	O	O
of	of	O	O
membranes	membranes	O	O
,	,	O	O
cholesteryl	cholesteryl	O	O
hemisuccinate	hemisuccinate	O	O
,	,	O	O
tris	tris	O	O
salt	salt	S_chemical	O
(	(	O	O
CS	cs	O	O
)	)	O	O
administration	administration	O	O
has	has	O	O
also	also	O	O
been	been	O	O
shown	shown	O	O
to	to	O	O
protect	protect	O	O
rats	rats	O	O
from	from	O	O
the	the	O	O
hepatotoxic	hepatotoxic	O	S_disease
effects	effects	O	O
of	of	O	O
carbon	carbon	B_chemical	O
tetrachloride	tetrachloride	I_chemical	O
(	(	O	O
CCl4	ccl4	O	O
)	)	O	O
.	.	O	O

To	to	O	O
further	further	O	O
our	our	O	O
understanding	understanding	O	O
of	of	O	O
the	the	O	O
mechanism	mechanism	O	O
of	of	O	O
CS	cs	O	O
cytoprotection	cytoprotection	O	O
,	,	O	O
we	we	O	O
examined	examined	O	O
in	in	O	O
rats	rats	O	O
and	and	O	O
mice	mice	O	O
the	the	O	O
protective	protective	O	O
abilities	abilities	O	O
of	of	O	O
CS	cs	O	O
and	and	O	O
the	the	O	O
non-hydrolyzable	non-hydrolyzable	O	O
ether	ether	O	O
form	form	O	O
of	of	O	O
CS	cs	O	O
,	,	O	O
gamma-cholesteryloxybutyric	gamma-cholesteryloxybutyric	O	O
acid	acid	O	O
,	,	O	O
tris	tris	O	O
salt	salt	S_chemical	O
(	(	O	O
CSE	cse	O	O
)	)	O	O
against	against	O	O
acetaminophen-	acetaminophen-	O	O
,	,	O	O
adriamycin-	adriamycin-	O	O
,	,	O	O
carbon	carbon	O	O
tetrachloride-	tetrachloride-	O	O
,	,	O	O
chloroform-	chloroform-	O	O
and	and	O	O
galactosamine-induced	galactosamine-induced	O	O
toxicity	toxicity	O	S_disease
.	.	O	O

The	the	O	O
results	results	O	O
of	of	O	O
these	these	O	O
studies	studies	O	O
demonstrated	demonstrated	O	O
that	that	O	O
CS-mediated	cs-mediated	O	O
protection	protection	O	O
is	is	O	O
not	not	O	O
selective	selective	O	O
for	for	O	O
a	a	O	O
particular	particular	O	O
species	species	O	O
,	,	O	O
organ	organ	O	O
system	system	O	O
or	or	O	O
toxic	toxic	O	O
chemical	chemical	O	O
.	.	O	O

A	a	O	O
24-h	24-h	O	O
pretreatment	pretreatment	O	O
of	of	O	O
both	both	O	O
rats	rats	O	O
and	and	O	O
mice	mice	O	O
with	with	O	O
a	a	O	O
single	single	O	O
dose	dose	O	O
of	of	O	O
CS	cs	O	O
(	(	O	O
100mg/kg	100mg/kg	O	O
,	,	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
,	,	O	O
resulted	resulted	O	O
in	in	O	O
significant	significant	O	O
protection	protection	O	O
against	against	O	O
the	the	O	O
hepatotoxic	hepatotoxic	O	S_disease
effects	effects	O	O
of	of	O	O
CCl4	ccl4	O	O
,	,	O	O
CHCl3	chcl3	O	O
,	,	O	O
acetaminophen	acetaminophen	S_chemical	O
and	and	O	O
galactosamine	galactosamine	O	O
and	and	O	O
against	against	O	O
the	the	O	O
lethal	lethal	O	O
(	(	O	O
and	and	O	O
presumably	presumably	O	O
cardiotoxic	cardiotoxic	O	S_disease
)	)	O	O
effect	effect	O	O
of	of	O	O
adriamycin	adriamycin	S_chemical	O
administration	administration	O	O
.	.	O	O

Maximal	maximal	O	O
CS-mediated	cs-mediated	O	O
protection	protection	O	O
was	was	O	O
observed	observed	O	O
in	in	O	O
experimental	experimental	O	O
animals	animals	O	O
pretreated	pretreated	O	O
24	24	O	O
h	h	S_chemical	O
prior	prior	O	O
to	to	O	O
the	the	O	O
toxic	toxic	O	O
insult	insult	O	O
.	.	O	O

These	these	O	O
data	data	O	O
suggest	suggest	O	O
that	that	O	O
CS	cs	O	O
intervenes	intervenes	O	O
in	in	O	O
a	a	O	O
critical	critical	O	O
cellular	cellular	O	O
event	event	O	O
that	that	O	O
is	is	O	O
an	an	O	O
important	important	O	O
common	common	O	O
pathway	pathway	O	O
to	to	O	O
toxic	toxic	O	O
cell	cell	O	O
death	death	O	S_disease
.	.	O	O

The	the	O	O
mechanism	mechanism	O	O
of	of	O	O
CS	cs	O	O
protection	protection	O	O
does	does	O	O
not	not	O	O
appear	appear	O	O
to	to	O	O
be	be	O	O
dependent	dependent	O	O
on	on	O	O
the	the	O	O
inhibition	inhibition	O	O
of	of	O	O
chemical	chemical	O	O
bioactivation	bioactivation	O	O
to	to	O	O
a	a	O	O
toxic	toxic	O	O
reactive	reactive	O	O
intermediate	intermediate	O	O
(	(	O	O
in	in	O	O
light	light	O	O
of	of	O	O
the	the	O	O
protection	protection	O	O
observed	observed	O	O
against	against	O	O
galactosamine	galactosamine	O	O
hepatotoxicity	hepatotoxicity	O	S_disease
)	)	O	O
.	.	O	O

However	however	O	O
,	,	O	O
based	based	O	O
on	on	O	O
the	the	O	O
data	data	O	O
presented	presented	O	O
,	,	O	O
we	we	O	O
can	can	O	O
not	not	O	O
exclude	exclude	O	O
the	the	O	O
possibility	possibility	O	O
that	that	O	O
CS	cs	O	O
administration	administration	O	O
inhibits	inhibits	O	O
chemical	chemical	O	O
bioactivation	bioactivation	O	O
.	.	O	O

Our	our	O	O
findings	findings	O	O
do	do	O	O
suggest	suggest	O	O
that	that	O	O
CS-mediated	cs-mediated	O	O
protection	protection	O	O
is	is	O	O
dependent	dependent	O	O
on	on	O	O
the	the	O	O
action	action	O	O
of	of	O	O
the	the	O	O
intact	intact	O	O
anionic	anionic	O	O
CS	cs	O	O
molecule	molecule	O	O
(	(	O	O
non-hydrolyzable	non-hydrolyzable	O	O
CSE	cse	O	O
was	was	O	O
as	as	O	O
protective	protective	O	O
as	as	O	O
CS	cs	O	O
)	)	O	O
,	,	O	O
whose	whose	O	O
mechanism	mechanism	O	O
has	has	O	O
yet	yet	O	O
to	to	O	O
be	be	O	O
defined	defined	O	O
.	.	O	O

